← Eichor
Condition: Ornithine Carbamoyltransferase Deficiency Disorder Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Ornithine Carbamoyltransferase Deficiency Disorder

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Ovarian Tissue Cryopreservation in Pre-Pubertal (OTC-Pre Pubertal)
Phase N/A · 1 location(s) · Erin Rowell · NCT05299710
A Study to Evaluate the Pharmacodynamics and Safety of ARCT-810 in Participants With OTCD
Phase 2 · 1 location(s) · Arcturus Therapeutics, Inc. · NCT06488313
Hepatic Histopathology in Urea Cycle Disorders
Phase N/A · 2 location(s) · Baylor College of Medicine · NCT04908319
An Open-label Study to Investigate ECUR-506 in Male Babies Less Than 9 Months of Age With Neonatal Onset OTC Deficiency
Phase 1/Phase 2 · 12 location(s) · iECURE, Inc. · NCT06255782
Long-term Follow-up (LTFU) Study of Participants in Any iECURE Protocol Using an Investigational Product (IP)
Phase N/A · 1 location(s) · iECURE, Inc. · NCT06805695
Abbott Vascular Medical Device Registry
Phase N/A · 37 location(s) · Abbott Medical Devices · NCT04573660
Optical Coherence Tomography And NEphropathy: The OCTANE Study
Phase N/A · 1 location(s) · University of Edinburgh · NCT02132741
Halting Ornithine Transcarbamylase Deficiency With Recombinant AAV in ChildrEn
Phase 1/Phase 2 · 1 location(s) · University College, London · NCT05092685
Systemic Biomarkers of Brain Injury From Hyperammonemia
Phase N/A · 1 location(s) · Children's National Research Institute · NCT04602325
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.